En Es
Categories

Industry News

Fujifilm Showcases Extended Product Line at ECR 2018

By Medimaging International staff writers
24 Apr 2018

Image: The FCT SPEEDIA series is designed for multiple routine examinations (Photo courtesy of Fujifilm Medical Systems).Fujifilm Medical Systems Europe (Duesseldorf, Germany), a provider of diagnostic imaging products and medical informatics solutions, showcased its broad, enhanced line up of products and solutions at the European Congress of Radiology (ECR) 2018. The products and solutions showcased by Fujifilm at ECR 2018 focused on women’s health, healthcare IT, artificial intelligence (AI), digital radiography (DR), computed tomography (CT), computed radiography and ultrasound.

At ECR 2018, Fujifilm introduced its new FCT SPEEDIA series CT systems with a compact size, powerful applications, and optimized workflow designed for multiple routine examinations. Both, the FCT Speedia and FCT Speedia HD offer fast scan rotation, sub-millimeter slice thickness, high power generator, and advanced image reconstruction algorithms to produce high resolution and high throughput imaging. The company also displayed its AMULET Innovality digital mammography system featuring two different acquisition modes and a revised face guard (WIP) to improve patient comfort during tomosynthesis exposures. Also on display was Fujifilm’s new Bellus II digital mammography workstation featuring advanced functions for image visualization and processing and a reporting utility designed to support mammography interpretation workflow.

Visitors at the company’s booth at ECR 2018 also viewed FDR Smart X, a flexible and modular room solution for DR that has been designed to complement FDR D-EVO II digital panels in all clinical applications and is available in ceiling-suspended or floor-mounted versions. Additionally, the company presented FDR D-EVO GL, the first 43x125cm digital panel ever for long view exposures, featuring an acquisition area that allows single-shot exposures of the whole spine and the inferior limbs.

Fujifilm’s FDR Go PLUS made its first appearance at ECR 2018. The new and improved mobile X-ray system offers better maneuverability and ergonomics due to its new and compact design, along with improved image quality than its predecessor. Visitors also tested the company’s lightweight and compact mobile X-ray system, FDR nano that features a revolutionary design and offers sensational image quality.

Among Fujifilm’s portfolio of medical informatics and Enterprise Imaging innovations showcased at ECR 2018 was its AI development initiative that aims to harness the power of AI to enhance the company’s imaging and informatics healthcare Synapse portfolio, which includes Synapse PACS, Synapse Cardiovascular and Synapse VNA and other solutions. SYNAPSE 5, the next generation PACS, is one of the fastest medical imaging solutions in the industry, offering sub-second delivery of extremely large datasets. Its underlying architecture promotes significantly less bandwidth consumption and tighter security. SYNAPSE VNA is a secure, comprehensive application for storing and providing access to complete imaging records. It securely integrates more specialties, more devices, and more data than any other VNA. The SYNAPSE MOBILITY Enterprise Viewer uses the latest server-side rendering technology to stream imaging securely and quickly to any authorized user. It can be used within applications, directly from the EHR, or on the company’s mobile device apps. Fujifilm also presented Syncro-Dose as a work-in-progress product at ECR 2018. Syncro-Dose is a comprehensive system for monitoring and managing patient radiation exposure at enterprise level across different imaging modalities and hospital facilities.

“Fujifilm’s commitment to a value based care is expressed into ECR 2018 theme of a more comprehensive care,” said Hiroaki Shimosaka, Senior VP Fujifilm Medical Systems Europe. “With our forward-thinking and collaborative approach we aim to provide more custom and integrated solution in order to enable our partners to improve patients’ experiences and outcome. The launch of the new FCT SPEEDIA, and the development of AI within SYNAPSE IT platform are two exceptional examples of how Fujifilm harness the full potential of the company’s core technologies to improve its role as comprehensive healthcare company.”



E-mail Print
FaceBook Twitter Google+ Linked in

Fujifilm

Offers diagnostic imaging products, including FCR” digital x-ray imaging and diagnostic systems, “Synapse” medical-use picture archiving and communications systems (PACS), dry imaging films/dry imagers, X-ray films, radiopharmaceuticals, digital endoscopes, nucleic acid isolation systems, healthcare products and pharmaceutical
More info

More articles about Fujifilm

24 Dec 2019
Fujifilm to Acquire Hitachi’s Diagnostic Imaging-related Business
 FUJIFILM Corporation (Tokyo, Japan) has entered into an agreement with Hitachi, Ltd. (Tokyo, Japan) to acquire its Diagnostic Imaging-related business to further expand its Healthcare business. By applying its proprietary image processing and artificial intelligence (AI) technologies to Hitachi’s extensive product lineup, Fujifilm aims to further expand its Medical Systems business and create new values to contribute to improve the quality of medical care.
Read More
12 Sep 2018
Fujifilm and IU School of Medicine to Study AI in Diagnostic Imaging
Fujifilm Corporation has entered into a joint research agreement with Indiana University School of Medicine to develop the application of artificial intelligence (AI) in medical imaging diagnostic support systems.
Read More

Additional news

21 Apr 2021
FDA Clears First-Ever AI Mammography Triage Software that Supports both 3D and 2D Mammography
The US Food and Drug Administration has cleared the first-ever artificial intelligence (AI) mammography triage software that supports both 3D and 2D mammography.
Read More
20 Apr 2021
Global Digital PCR and Real-Time PCR Market Growth Driven by Increasing Cases of Infectious Diseases
Increasing cases of infectious diseases, rising geriatric population and growing number of genetic disorders will propel the growth of the global digital PCR and real-time PCR market over the next decade. Additionally, PCR advances, fulfillment of the human genome project, and expanding R&D will increase the utilization of biomarker profiling for sickness diagnostics, thus further driving market growth.
Read More
19 Apr 2021
Siemens Completes Acquisition of Varian to Create Integrated Portfolio of Imaging, Laboratory Diagnostics, AI and Cancer Treatment
Siemens Healthineers (Erlangen, Germany) has successfully completed the acquisition of Varian Medical Systems, Inc. (Palo Alto, CA, USA), thus strengthening its position as a holistic partner in healthcare.
Read More
16 Apr 2021
Eppendorf Introduces Multipurpose Centrifuge 5910 Ri to Accelerate Results
Eppendorf AG (Hamburg, Germany) has introduced a new centrifuge designed to increase efficiency in the laboratory, Centrifuge 5910 Ri, a successor to the company’s popular Centrifuge 5910 R.
Read More
16 Apr 2021
Artificial Intelligence (AI) in Medical Diagnostics Market to Reach USD 3.86 Billion by 2025
The global Artificial Intelligence (AI) in Medical Diagnostics Market is projected to grow at a CAGR of 50.2% from USD 0.5 billion in 2020 to USD 3.86 billion by 2025, driven primarily by government initiatives to increase the adoption of AI-based technologies, increasing demand for AI tools in the medical field, growing focus on reducing the workload of radiologists, influx of large and complex datasets, growth in funding for AI-based start-ups, and growing number of cross-industry partnerships and collaborations.
Read More
15 Apr 2021
Microsoft Acquires Radiology Vendor Nuance to Deliver New Cloud and AI Capabilities Across Healthcare
Microsoft Corporation (Redmond, WA, USA) will acquire Nuance Communications, Inc. (Burlington, MA, USA) in an all-cash transaction valued at USD 19.7 billion to combine their solutions and expertise that will deliver new cloud and AI capabilities across healthcare and other industries.
Read More
14 Apr 2021
Zoll Medical Acquires CSA Systems Manufacturer Respicardia
 ZOLL Medical Corporation (Chelmsford, MA, USA), an Asahi Kasei company, has acquired Respicardia, Inc. (Minnetonka, MN, USA), a provider of novel implantable neurostimulators for the treatment of moderate to severe Central Sleep Apnea (CSA).
Read More
13 Apr 2021
DiaSorin to Acquire Luminex to Broaden Positioning in Molecular Diagnostics Space
DiaSorin S.p.A. (?Saluggia?, Italy) has announced that its Board of Directors has unanimously approved and signed a definitive merger agreement for DiaSorin to acquire Luminex Corporation (Austin, TX, USA) for approximately USD 1.8 billion.
Read More
13 Apr 2021
Philips Collaborates with AI Startup Ibex to Accelerate Adoption of AI-Powered Digital Pathology Solutions
Royal Philips (Amsterdam, The Netherlands) and Ibex Medical Analytics (Tel Aviv, Israel) have entered into a strategic collaboration to jointly promote their digital pathology and AI solutions to hospitals, health networks and pathology labs worldwide.
Read More
Copyright © 2000-2021 TradeMed.com. All rights reserved. | Terms And Conditions